British Prime Minister welcomes further £3 million of research funding for leading UK and Israeli scientists announced by the British Council.
The third BIRAX Research Call, which opened on 10th September, was discussed by Prime Minister David Cameron and Prime Minister Netanhyau and will fund joint research to tackle the most urgent global health challenges.
A Downing Street spokesperson said:
“The two leaders welcomed the growing economic ties between the UK and Israel, particularly the progress that had been made since the PM’s visit in a number of areas, including research and science, with an additional £3 million of new funding for bilateral medical research projects in 2017.
BIRAX brings together British and Israeli scientists to tackle some of the world’s most challenging diseases including cardiovascular and liver disease, diabetes and Parkinson’s. To date the British Council has raised over £10 million for BIRAX.
Over £7 million has been committed to 15 world-class projects including eight joint medical research projects announced in February 2015. These included research to use heart cells to restore damaged heart muscle and the use of breath tests for the diagnosis of Parkinson’s Disease.
As well as a general call for proposals, the Third Call includes a particular focus on Alzheimer’s, Arthritis, Cardiovascular Disease, Type 1 Diabetes, MS and Parkinson’s. Successful research projects will be supported by leading British medical research foundations including Alzheimer’s Drug Discovery Foundation, Alzheimer’s Society, Arthritis Research UK, the British Heart Foundation, JDRF, the MS Society and Parkinson’s UK. The call is now closed.
The deadline for full proposals is July 2016 and the successful projects will be announced in January 2017.
For further information and updates see our BIRAX 3rd call page